LENSAR, Inc. (LNSR)Healthcare | Medical Devices | Orlando, United States | NasdaqCM
8.30 USD
-0.16
(-1.891%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 8.36 +0.06 (0.723%) ⇧ (Aug. 28, 2026, 4:39 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 3:16 a.m. EDT
The investment case for LENSAR is currently paralyzed by the collapse of the Alcon acquisition. While the company boasts impressive operational metrics—nearly 58% profit margins and robust revenue growth—the stock has been punished severely by the market's reaction to the deal failure. The recent price action shows a tentative recovery from lows near $5, yet the path forward remains obscured by regulatory hurdles and the absence of a definitive strategic partner. For the short term, the setup is cautiously optimistic but fragile. The stock is trading well above its 200-day average, suggesting some buyers are stepping in at these levels, but the statistical forecast model offers almost no directional guidance, highlighting the noise inherent in this situation. The options market confirms this tension, with traders betting on a 'reset' scenario rather than a steady climb. Long-term, the business fundamentals are actually quite strong, with a fortress-like balance sheet and high profitability. However, the lack of a clear growth catalyst post-Alcon prevents a higher valuation multiple. Until the company can demonstrate a new, sustainable growth engine or secure a new major partnership, the risk of another disappointment outweighs the potential for immediate capital appreciation. Investors should wait for clarity on the next strategic chapter before committing significant capital. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.138417 |
| MSTL | 0.140059 |
| AutoETS | 0.147839 |
| AutoARIMA | 0.147899 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 30% |
| H-stat | 26.83 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.031 |
| Excess Kurtosis | -0.84 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 8.299 |
| Revenue per Share | 4.962 |
| Market Cap | 101,972,680 |
| Trailing P/E | 41.50 |
| Forward P/E | -11.69 |
| Beta | 0.88 |
| Profit Margins | 57.57% |
| Website | https://www.lensar.com |
As of Aug. 22, 2026, 3:16 a.m. EDT: Speculators are positioning for a binary resolution to the failed Alcon merger. Call volume is heavily skewed toward out-of-the-money strikes at $10, suggesting a hope for a deal reset or a significant recovery rally. Conversely, put volume is concentrated at the $5 strike, indicating a fear of further downside if the regulatory impasse persists. Implied volatility remains elevated relative to deep OTM strikes, reflecting uncertainty rather than a clear directional bet.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.31497973 |
| Address1 | 2,800 Discovery Drive |
| All Time High | 17.31 |
| All Time Low | 1.8 |
| Ask | 10.62 |
| Ask Size | 2 |
| Audit Risk | 8 |
| Average Analyst Rating | 1.0 - Strong Buy |
| Average Daily Volume10 Day | 147,220 |
| Average Daily Volume3 Month | 119,337 |
| Average Volume | 119,337 |
| Average Volume10Days | 147,220 |
| Beta | 0.88 |
| Bid | 8.27 |
| Bid Size | 1 |
| Board Risk | 6 |
| Book Value | 1.214 |
| City | Orlando |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 9 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 8.3 |
| Current Ratio | 2.394 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 8.52 |
| Day Low | 8.23 |
| Debt To Equity | 8.299 |
| Display Name | LENSAR |
| Earnings Call Timestamp End | 1,786,624,200 |
| Earnings Call Timestamp Start | 1,786,624,200 |
| Earnings Timestamp | 1,786,624,200 |
| Earnings Timestamp End | 1,794,486,600 |
| Earnings Timestamp Start | 1,794,486,600 |
| Ebitda | -16,328,000 |
| Ebitda Margins | -0.27094 |
| Enterprise To Ebitda | -6.405 |
| Enterprise To Revenue | 1.735 |
| Enterprise Value | 104,572,680 |
| Eps Current Year | -0.08 |
| Eps Forward | -0.71 |
| Eps Trailing Twelve Months | 0.2 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 6.3881 |
| Fifty Day Average Change | 1.9119 |
| Fifty Day Average Change Percent | 0.29929087 |
| Fifty Two Week Change Percent | -31.497972 |
| Fifty Two Week High | 12.94 |
| Fifty Two Week High Change | -4.6399994 |
| Fifty Two Week High Change Percent | -0.35857803 |
| Fifty Two Week Low | 4.95 |
| Fifty Two Week Low Change | 3.3500004 |
| Fifty Two Week Low Change Percent | 0.67676777 |
| Fifty Two Week Range | 4.95 - 12.94 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,601,645,400,000 |
| Float Shares | 8,842,506 |
| Forward Eps | -0.71 |
| Forward P E | -11.690142 |
| Free Cashflow | -24,391,250 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 150 |
| Fullday Change | -0.16 |
| Fullday Change Percent | -1.89125 |
| Fullday Price | 8.36 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,785,542,400 |
| Gross Margins | 0.48339 |
| Gross Profits | 29,131,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.21521999 |
| Held Percent Institutions | 0.45979 |
| Implied Shares Outstanding | 12,285,865 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida. |
| Long Name | LENSAR, Inc. |
| Market | us_market |
| Market Cap | 101,972,680 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_41699596 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | 14,700,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 104,061,276 |
| Number Of Analyst Opinions | 2 |
| Open | 8.43 |
| Operating Cashflow | -7,293,000 |
| Operating Margins | 0.12937 |
| Overall Risk | 8 |
| Payout Ratio | 0.0 |
| Phone | 888 536 7271 |
| Post Market Change | 0.059999466 |
| Post Market Change Percent | 0.72288513 |
| Post Market Price | 8.36 |
| Post Market Time | 1,787,949,541 |
| Previous Close | 8.46 |
| Price Eps Current Year | -103.75001 |
| Price Hint | 2 |
| Price To Book | 6.836903 |
| Price To Sales Trailing12 Months | 1.6920995 |
| Profit Margins | 0.57573 |
| Quick Ratio | 1.03 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.0 |
| Region | US |
| Regular Market Change | -0.16 |
| Regular Market Change Percent | -1.89125 |
| Regular Market Day High | 8.52 |
| Regular Market Day Low | 8.23 |
| Regular Market Day Range | 8.23 - 8.52 |
| Regular Market Open | 8.43 |
| Regular Market Previous Close | 8.46 |
| Regular Market Price | 8.3 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 142,330 |
| Return On Assets | -0.18663 |
| Return On Equity | 3.5730398 |
| Revenue Growth | 0.184 |
| Revenue Per Share | 4.962 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 9 |
| Shares Outstanding | 12,285,865 |
| Shares Percent Shares Out | 0.033800002 |
| Shares Short | 415,434 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 483,171 |
| Short Name | LENSAR, Inc. |
| Short Percent Of Float | 0.0468 |
| Short Ratio | 2.89 |
| Source Interval | 15 |
| State | FL |
| Symbol | LNSR |
| Target High Price | 13.0 |
| Target Low Price | 10.0 |
| Target Mean Price | 11.5 |
| Target Median Price | 11.5 |
| Total Cash | 13,565,000 |
| Total Cash Per Share | 1.104 |
| Total Debt | 2,381,000 |
| Total Revenue | 60,264,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 0.2 |
| Trailing P E | 41.5 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 8.389575 |
| Two Hundred Day Average Change | -0.089574814 |
| Two Hundred Day Average Change Percent | -0.0106769195 |
| Type Disp | Equity |
| Volume | 142,330 |
| Website | https://www.lensar.com |
| Zip | 32,826 |